Asker Healthcare Group AB (STO:ASKER)
Sweden flag Sweden · Delayed Price · Currency is SEK
91.64
-0.74 (-0.80%)
Nov 28, 2025, 5:29 PM CET

Asker Healthcare Group AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
16,41415,02513,45311,7189,354
Revenue Growth (YoY)
22.01%11.68%14.81%25.27%-
Cost of Revenue
9,7779,1478,9347,9366,741
Gross Profit
6,6375,8784,5193,7822,613
Selling, General & Admin
5,5394,8513,8862,6741,778
Amortization of Goodwill & Intangibles
---16768
Other Operating Expenses
6-15-7--
Operating Expenses
5,5454,8363,8793,0692,008
Operating Income
1,0921,042640713605
Interest Expense
-401-302-264-186-23
Interest & Investment Income
1879311
Currency Exchange Gain (Loss)
-1-12493-27
Other Non Operating Income (Expenses)
-70-73-34-60-12
EBT Excluding Unusual Items
807675369561544
Gain (Loss) on Sale of Assets
3232---
Other Unusual Items
-132-149-61--
Pretax Income
688558308561544
Income Tax Expense
20718310312774
Earnings From Continuing Operations
481375205434470
Minority Interest in Earnings
-12-15-2-4-3
Net Income
469360203430467
Net Income to Common
529360203430467
Net Income Growth
131.03%77.34%-52.79%-7.92%-
Shares Outstanding (Basic)
295263262258236
Shares Outstanding (Diluted)
295263262258236
Shares Change (YoY)
12.38%0.40%1.55%9.55%-
EPS (Basic)
1.801.370.771.671.98
EPS (Diluted)
1.801.370.771.671.98
EPS Growth
131.88%76.63%-53.51%-15.95%-
Free Cash Flow
683879901853258
Free Cash Flow Per Share
2.323.343.443.301.09
Gross Margin
40.44%39.12%33.59%32.27%27.93%
Operating Margin
6.65%6.93%4.76%6.08%6.47%
Profit Margin
3.22%2.40%1.51%3.67%4.99%
Free Cash Flow Margin
4.16%5.85%6.70%7.28%2.76%
EBITDA
1,5371,351933896670
EBITDA Margin
9.36%8.99%6.93%7.65%7.16%
D&A For EBITDA
44530929318365
EBIT
1,0921,042640713605
EBIT Margin
6.65%6.93%4.76%6.08%6.47%
Effective Tax Rate
30.09%32.80%33.44%22.64%13.60%
Revenue as Reported
---11,7519,378
Source: S&P Global Market Intelligence. Standard template. Financial Sources.